CORT: CORCEPT THERAPEUTICS INC insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 12 sales totaling $6.18M in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-15Wilson James NDirector$762Kyes
2026-10-15Wilson James NDirector$351Kyes
2026-10-15Wilson James NDirector$35Kyes
2026-10-02Vieira Roberto WandenkolkPresident$126Kyes
2026-10-02Vieira Roberto WandenkolkPresident$241Kyes
2026-10-02Vieira Roberto WandenkolkPresident$600Kyes
2026-10-02Lyon Joseph DouglasOfficer$514Kyes
2026-10-02Lyon Joseph DouglasOfficer$553Kyes
2026-10-02Maduck SeanOfficer$1.84Myes
2026-10-02Maduck SeanOfficer$1.02Myes
2026-10-01Lyon Joseph DouglasOfficer$93Kyes
2026-10-01Maduck SeanOfficer$48Kyes

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-08-13Fell below 5%Renaissance Technologies LLC4.90%SEC

Institutional ownership (Q2 2026)

424 institutions reported holding $6.37B of CORCEPT THERAPEUTICS INC on Form 13F (352 the quarter before). 125 opened a new position and 53 sold out. Shares held by institutions: +4%.

Largest holdersSharesValue
BlackRock, Inc.12,432,023$1.08B
RENAISSANCE TECHNOLOGIES LLC5,261,628$457.50M
VANGUARD PORTFOLIO MANAGEMENT LLC5,044,638$438.63M
VANGUARD CAPITAL MANAGEMENT LLC4,172,482$362.80M
Parallel Advisors, LLC3,962,177$344.51M
FMR LLC3,337,618$290.21M
STATE STREET CORP3,279,381$285.15M
AQR CAPITAL MANAGEMENT LLC2,582,561$224.55M
GEODE CAPITAL MANAGEMENT, LLC2,532,198$220.21M
FIRST TRUST ADVISORS LP1,829,545$159.08M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.